Francisco Fanjul

12PUBLICATIONS
41CO-AUTHORS
Disease surveillanceBehavioural epidemiologyMajor global burdens of diseaseGene and molecular therapyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 24, 2026
Implementing Indicator Condition-Guided HIV Screening Alerts in the Emergency Department: Lessons Learned from a Case Study.

|Jan 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort.

Jesús Troya, Rafael Mican, María José Galindo

|Dec 30, 2025
The Validation of Mortality Risk Indexes for Predicting Long-Term Outcomes in People Living with HIV in a Spanish Cohort (eVIHa).

Sophia Pinecki Socias, Marc Moragues Serra, Francisca Artigues Serra

|Nov 27, 2025
HIV Therapy: The Latest Developments in Antiviral Drugs-A Scoping Review.

Francisco Fanjul, Meritxell Gavalda, Antoni Campins

|Oct 21, 2025
Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort.

Jesús Troya, María Luisa Montes, María José Galindo

|Apr 05, 2023
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

R Palacios, C Gómez-Ayerbe, J L Casado

Pageof 2

Frequent Collaborators

2 joint publications

Gloria Sampériz

2 joint publications

Adrián Rodríguez

2 joint publications

Luis Buzón-Martín

2 joint publications

Carmen Hidalgo-Tenorio